Last updated on December 2018

Korean Post-marketing Surveillance for Xeljanz

Brief description of study

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

Clinical Study Identifier: NCT02984020

Contact Investigators or Research Sites near you

Start Over

Pfizer Call Center

Chonbuk National University Hospital, Department of Rheumatology
Chonju, Korea, Republic of
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.